Share on LinkedInShare on LinkedIn

ARTICLE · 15 JUNE 2016

Best Practices For Patenting Antibodies

There are several rules to watch out for when seeking patent protection for antibodies in Brazil. Despite the continuing efforts to harmonise patent practice in all countries, some differences persist.

BrazilIntellectual Property

There are several rules to watch out for when seeking patent protection for antibodies in Brazil.

Despite the continuing efforts to harmonise patent practice in all countries, some differences persist. When it comes to technological domains like biotechnology, minor differences can yield a huge impact in the end. This is the case of antibody patentability. It is not news that the Brazilian practice is inspired by the European one, but most Brazilian practitioners will agree that it comes with several kinds of restrictions.

In Europe, although antibodies are most commonly defined according to their amino acid sequences (VH and VL domains or CDRs), it is also acceptable to claim antibodies in terms of their functions provided that the skilled person would be able to isolate or make such antibodies without experimental uncertainties.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from